X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs FULFORD INDIA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE FULFORD INDIA CADILA HEALTHCARE/
FULFORD INDIA
 
P/E (TTM) x 16.9 398.8 4.2% View Chart
P/BV x 3.8 6.2 61.0% View Chart
Dividend Yield % 1.1 0.1 1,275.6%  

Financials

 CADILA HEALTHCARE   FULFORD INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
FULFORD INDIA
Mar-14
CADILA HEALTHCARE/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs558942 59.2%   
Low Rs362450 80.3%   
Sales per share (Unadj.) Rs116.3691.4 16.8%  
Earnings per share (Unadj.) Rs17.911.5 155.9%  
Cash flow per share (Unadj.) Rs23.115.4 150.6%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.80.3 264.9%  
Book value per share (Unadj.) Rs85.4380.0 22.5%  
Shares outstanding (eoy) m1,023.743.90 26,249.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.0 392.7%   
Avg P/E ratio x25.760.7 42.4%  
P/CF ratio (eoy) x19.945.3 43.9%  
Price / Book Value ratio x5.41.8 293.9%  
Dividend payout %19.617.4 112.3%   
Avg Mkt Cap Rs m470,6642,714 17,339.5%   
No. of employees `00011.80.4 2,661.9%   
Total wages/salary Rs m18,545505 3,672.3%   
Avg. sales/employee Rs Th10,072.76,073.0 165.9%   
Avg. wages/employee Rs Th1,569.11,137.4 138.0%   
Avg. net profit/employee Rs Th1,547.7100.7 1,537.3%   
INCOME DATA
Net Sales Rs m119,0492,696 4,415.1%  
Other income Rs m1,132125 902.7%   
Total revenues Rs m120,1812,822 4,259.0%   
Gross profit Rs m28,475-46 -61,368.5%  
Depreciation Rs m5,38815 35,447.4%   
Interest Rs m91110 9,589.5%   
Profit before tax Rs m23,30854 42,924.5%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,64410 58,791.7%   
Profit after tax Rs m18,29245 40,921.7%  
Gross profit margin %23.9-1.7 -1,390.0%  
Effective tax rate %24.217.7 137.0%   
Net profit margin %15.41.7 926.9%  
BALANCE SHEET DATA
Current assets Rs m82,0051,738 4,717.5%   
Current liabilities Rs m60,720545 11,147.4%   
Net working cap to sales %17.944.3 40.4%  
Current ratio x1.43.2 42.3%  
Inventory Days Days7348 150.9%  
Debtors Days Days984 2,283.7%  
Net fixed assets Rs m83,70312 703,386.6%   
Share capital Rs m1,02439 2,625.6%   
"Free" reserves Rs m86,4211,443 5,989.0%   
Net worth Rs m87,4451,482 5,900.5%   
Long term debt Rs m25,5510-   
Total assets Rs m180,6532,077 8,699.0%  
Interest coverage x26.66.7 395.9%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.71.3 50.8%   
Return on assets %10.62.6 407.3%  
Return on equity %20.93.0 693.5%  
Return on capital %22.04.3 510.8%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m42,68317 248,157.0%   
Fx outflow Rs m11,242673 1,670.0%   
Net fx Rs m31,441-656 -4,793.1%   
CASH FLOW
From Operations Rs m9,19390 10,214.4%  
From Investments Rs m-9,737105 -9,308.8%  
From Financial Activity Rs m515-14 -3,652.5%  
Net Cashflow Rs m-29181 -16.1%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.3 3.8 218.4%  
FIIs % 5.9 0.1 5,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 21.2 51.9%  
Shareholders   44,069 4,783 921.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON   PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 324 Points Lower; Metal and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 25, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - STRIDES PHARMA SCIENCE COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS